Ingelheim, Germany — Boehringer Ingelheim, a leading research-driven biopharmaceutical company, presented a new corporate branding that is designed to inspire deeper connection with the company’s diverse customers, partners, and employees…. Read More
IMC Interim President Announcement Dear Partner, As I conclude my leadership of IMC on November 16th, I am thrilled to inform you that David Renwick is now the Interim President,… Read More
All six patients in the first cohort (Cohort A) were successfully implanted with the 8-channel Cell Pouch System with post-transplant follow-up periods ranging from 6 months to 3.5 years; •… Read More
Net sales of $1.72 billion, decrease of 7.3%; core organic decline of 7.9% Net income of $108.4 million; Adjusted EBITDA of $317.8 million Diluted GAAP EPS of $0.16; adjusted EPS of $0.25 Operating cash flow… Read More
VANCOUVER, BC –(BUSINESS WIRE)–Avivo Biomedical Inc. (“Avivo”), a British Columbia-based preclinical-stage company, proudly announces a collaboration with Mayo Clinic through a know-how license agreement centering on Avivo’s technology for Enzyme-Converted type O (“ECO”)… Read More
